hidradenitis suppurativa

Oak Ridge National Laboratory / Wikimedia (CC BY 2.0)

Insmed Halts Development of TPX-201 for Hidradenitis Suppurativa After Phase 2 Trial Failure

Insmed Incorporated announced the discontinuation of its topical drug TPX-201 for hidradenitis suppurativa following negative results from a Phase 2 clinical trial. The trial did not meet its primary endpoint of achieving Hidradenitis Suppurativa Clinical Response at Week 12. The…